Your browser doesn't support javascript.
loading
Imetelstat, a telomerase inhibitor, differentially affects normal and malignant megakaryopoiesis.
Mosoyan, G; Kraus, T; Ye, F; Eng, K; Crispino, J D; Hoffman, R; Iancu-Rubin, C.
Affiliation
  • Mosoyan G; The Tisch Cancer Institute, Division of Hematology and Medical Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY USA.
  • Kraus T; Center for Therapeutic Antibody Development, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Ye F; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Eng K; OncoMed Pharmaceuticals, Redwood City, CA, USA.
  • Crispino JD; Department of Medicine-Hematology/Oncology, Northwestern University Feinberg School of Medicine, Evanston, IL, USA.
  • Hoffman R; Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Evanston, IL, USA.
  • Iancu-Rubin C; The Tisch Cancer Institute, Division of Hematology and Medical Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY USA.
Leukemia ; 31(11): 2458-2467, 2017 11.
Article in En | MEDLINE | ID: mdl-28270692
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Megakaryocytes / Niacinamide / Telomerase / Enzyme Inhibitors / Indoles Limits: Humans Language: En Journal: Leukemia Year: 2017 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Megakaryocytes / Niacinamide / Telomerase / Enzyme Inhibitors / Indoles Limits: Humans Language: En Journal: Leukemia Year: 2017 Document type: Article